5301 Stevens Creek Blvd
Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions.
Agilent focuses its expertise on six key markets, where we help our customers achieve their goals:
Food: Agilent helps ensure that our global food supply is free of contaminants—whether chemical, viral, bacterial or microbiological. Our customers include government regulators and labs that control food safety, as well as private companies that produce, package and sell food to the public.
Environmental and Forensics: From pesticides to pharmaceutical residues to trace metals, we provide fast, accurate and sensitive methods for monitoring contaminants affecting quality of life. Agilent solutions also play an important role in law enforcement by providing robust tools and instruments to analyze and verify evidence at trial, and keeping the world’s top-performing athletes honest.
Pharmaceutical: Agilent has one of the broadest solutions portfolios of any company serving the pharmaceutical industry. Our solutions provide precise answers for every segment of the pharmaceutical industry, from disease research and drug discovery to drug development, manufacturing and quality control. The start-to-finish solution set means customers can get products to market faster. Customers trust us to help them test the purity of their therapeutics. Agilent also ensures that their instruments and processes conform to the highest compliance regulations.
Diagnostics: Agilent gives doctors a head start in the fight against cancer and other diseases. Our solutions help pathology laboratories deliver fast, accurate information to the doctors, hospitals and medical centers they serve. We help medical professionals make more accurate diagnoses so patients can receive the most effective therapies.
Chemical and Energy: The world runs on energy, and energy companies need to locate, extract and refine fuels efficiently and cost-effectively. Our solutions help customers maximize their production and predict failures in their refineries before they happen. Agilent also helps energy researchers investigate biofuels, renewable fuels and other forms of alternate energy.
Research: Most life sciences and diagnostics research is done at top-tier universities, with funding from governments around the world. Agilent is helping these researchers learn more about cancer, cardiovascular diseases, diabetes, Alzheimer’s, Parkinson’s, autism and other ailments. Our instruments, software and sample preparation solutions help scientists conduct faster, more accurate research.
474 articles with Agilent
High-performance Liquid Chromatography (HPLC) Market 2019-2023 | Evolving Opportunities with Agilent Technologies, Inc. and GE Healthcare | Technavio
Technavio has been monitoring the global high-performance liquid chromatography market since 2016 and the market is poised to grow by USD 1.05 billion during 2019-2023, progressing at a CAGR of almost 5% during the forecast period.
Achieves industry leadership recognition in DJSI’s Life Sciences Tools and Services category for fifth consecutive year
Combined portfolio enables Agilent to provide a more complete and integrated solution for customers in the important and fast-growing area of live cell analysis
New State of the Art Facility Increases Agilent’s Capacity to Produce Nucleic Acid-Based Therapeutics
New facility in Frederick, Colorado, to produce high-quality molecules with the potential to treat cancer and other diseases
Agilent Technologies, Inc. announced that a quarterly dividend of 16.4 cents per share of common stock will be paid on July 24, 2019, to all shareholders of record as of the close of business on July 2, 2019.
The gene sequencing industry has really taken off in the years since the Human Genome Project’s rough draft was announced in June 2000.
PD-L1 IHC 22C3 pharmDx Can Now Be Used to Identify a Broader Range of NSCLC Patients for First-line Treatment With KEYTRUDA® (pembrolizumab)
Agilent Technologies to Host Webcast of Second-Quarter Fiscal Year 2019 Financial Results Conference Call
Agilent Technologies Inc. will release second-quarter fiscal 2019 financial results after the stock market closes on May 14.
The San Francisco Business Times came out with a list of 64 major Bay Area employers and their median pay, which they then compared to their chief executives’ annual compensation.
Agilent Technologies Inc. (NYSE: A) announced today the shipping of a new instrument that offers laboratories a more affordable, low-throughput option for analyzing the quality of RNA and DNA samples.
Agilent Technologies Inc. announced that a quarterly dividend of 16.4 cents per share of common stock will be paid on April 24, 2019, to all shareholders of record as of the close of business on April 2, 2019.
Fully automated Magnis system delivers reproducible results for molecular laboratories
Company expands GC portfolio with self-aware predictive technology
Agilent Technologies to Present at Goldman Sachs Healthcare CEO Conference and JP Morgan Healthcare Conference
Agilent Technologies Inc. (NYSE: A) today announced the following webcasts for the investment community:
Agilent delivers outstanding quarter wrapping up an excellent 2018
Acquisition Brings Together Two Pioneers in Cellular Function and Metabolism Measurements
Fully integrated solution increases productivity of environmental labs
Agilent Introduces Unique Next Generation Sequencing-based Preimplantation Genetic Testing (PGT) Solution
Agilent Technologies Inc. (NYSE: A) today announced the introduction of Agilent OnePGT, a genome-wide, next-generation sequencing (NGS) solution for preimplantation genetic testing (PGT).
Agilent Technologies Inc. today announced that it has been recognized by Forbes as one of the World’s Best Employers.
Agilent Technologies to Host Webcast of Fourth-Quarter Fiscal Year 2018 Financial Results Conference Call
Agilent Technologies Inc. (NYSE: A) will release fourth-quarter fiscal 2018 financial results after the stock market closes on November 19.